Pneumocystis carinii pneumonia in a patient on etanercept for psoriatic arthritis

Irish Journal of Medical Science

Volumn 176, Issue 4, 2007, Pages 309-311

  Lahiff, Conor ^a   Khiaron, O B ^a   Nolan, N ^a   Chadwick, Geoff A ^a  

^a St Columcille s Hospital   (Ireland)

Author keywords

Co trimoxazole; Etanercept; Grocott' s silver stain; Pneumocystis carinii; Psoriatic arthritis

Indexed keywords

COTRIMOXAZOLE; ETANERCEPT; METHOTREXATE;

ADULT; ANAMNESIS; ARTERIAL BLOOD; ARTICLE; BLOOD CELL COUNT; BLOOD GAS ANALYSIS; CASE REPORT; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; DRUG RESPONSE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LUNG EMBOLISM; MALE; PHYSICAL EXAMINATION; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PSORIATIC ARTHRITIS; TRANSBRONCHIAL BIOPSY; TREATMENT DURATION;

ADULT; ARTHRITIS, PSORIATIC; BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; PNEUMONIA, PNEUMOCYSTIS; RECEPTORS, TUMOR NECROSIS FACTOR; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 36549063802     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-007-0087-x     Document Type: Article

References (12)

1. The National Institute of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia (1990) Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323:1500-1504
2. Pareja JG, Garland R, Koziel H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113:1215-1224
3. Bakleh M, Tleyjeh I, Matteson EL, Osmon DR, Berbari EF (2005) Infectious complications of tumor necrosis factor-α antagonists. Int J Dermatol 44(6):443-448
4. Weinblatt ME, Kremer JM, Bankhurst AD et al (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259
5. Olsen NJ, Stein CM (2004) New drugs for rheumatoid arthritis. N Engl J Med 350:2167-2179
6. Oien KA, Black A, Hunter JA, Madhok R (1995) Pneumocystis carinii pneumonia in a patient with rheumatoid arthritis, not on immunosuppressive therapy and in the absence of human immunodeficiency virus infection. Br J Rheumatol 34:677-679
7. Mori S, Imamura F, Kiyofuji C et al (2006) Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumour necrosis factor alpha neutralizing antibody. Mod Rheumatol 16(1):58-62
8. Gruden JF, Huang L, Turner J et al (1997) High-resolution CT in the evaluation of clinically suspected Pneumocystis carinii pneumonia in AIDS patients with normal, equivocal, or nonspecific radiographic findings. AJR Am J Roentgenol 169:967-975
9. Shelhamer JH, Gill VJ, Quinn TC et al (1996) The laboratory evaluation of opportunistic pulmonary infections. Ann Intern Med 124:585-599
10. Saito K, Nakayamada S, Nakano K et al (2004) Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: Re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases. Rheumatology (Oxford) 43:479-485
11. Navin R (2001) Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of Pneumocystis carinii pneumonia in patients with HIV-1: A prospective study. Lancet 358:545-549
12. Krebs S, Gibbons RB (1996) Low-dose methotrexate as a risk factor for Pneumocystis carinii pneumonia. Mil Med 161(1):58-60